Uromedica, Inc.

Plymouth,  MN 
United States
  • Booth: 431

ProACT is indicated for the treatment of men who have stress incontinence arising from intrinsic sphincter deficiency of at least twelve months duration following radical prostatectomy or transurethral resection of the prostate (TURP). The ProACT therapy consists of two small, adjustable silicone balloons connected with tubing to a filling port. The procedure lasts approximately 30 minutes and can be performed in an outpatient setting. The balloons are surgically placed in the area where the prostate was removed or resected and the ports are placed underneath the skin. The fluid-filled balloons provide pressure and support at the bladder neck which protects against accidental leaking of urine that can occur. When there is a need to urinate, passing urine requires only a normal amount of bladder effort. The balloon volume can be adjusted to achieve optimal continence. Given the minimally invasive nature of the procedure and the low risk profile, ProACT provides a therapeutic alternative to more invasive alternatives for all severities of stress incontinence. ProACT is FDA approved and commercially available in the US with Medicare reimbursement.

Brands: ProACT, ACT